Analysts at FBR Capital Reiterate their “Neutral” rating for Warrior Met Coal (HCC) with $24 PT; Amarin Plc Ads (AMRN) Sellers Increased By 0.19% Their Shorts





September 25, 2017 – By Richard Conner







Among 9 analysts covering HCC Insurance Holdings (NYSE:HCC), 3 have Buy rating, 2 Sell and 4 Hold. Therefore 33% are positive. HCC Insurance Holdings has $27 highest and $18 lowest target. $23’s average target is -5.27% below currents $24.28 stock price. HCC Insurance Holdings had 17 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Morgan Stanley given on Monday, May 8. Credit Suisse initiated Warrior Met Coal LLC (NYSE:HCC) on Monday, May 8 with “Outperform” rating. RBC Capital Markets maintained it with “Outperform” rating and $27 target in Friday, August 4 report. RBC Capital Markets maintained Warrior Met Coal LLC (NYSE:HCC) on Monday, June 12 with “Buy” rating. RBC Capital Markets maintained Warrior Met Coal LLC (NYSE:HCC) rating on Monday, July 31. RBC Capital Markets has “Buy” rating and $2400 target. The firm has “Equal-Weight” rating given on Tuesday, June 27 by Morgan Stanley. RBC Capital Markets initiated Warrior Met Coal LLC (NYSE:HCC) on Monday, May 8 with “Outperform” rating. RBC Capital Markets maintained Warrior Met Coal LLC (NYSE:HCC) rating on Wednesday, September 6. RBC Capital Markets has “Buy” rating and $27.0 target. As per Thursday, September 3, the company rating was downgraded by Zacks. On Thursday, April 20 the stock rating was initiated by FBR Capital with “Mkt Perform”.

Amarin Corporation Plc Ads (NASDAQ:AMRN) had an increase of 0.19% in short interest. AMRN’s SI was 7.36 million shares in September as released by FINRA. Its up 0.19% from 7.34 million shares previously. With 1.40M avg volume, 5 days are for Amarin Corporation Plc Ads (NASDAQ:AMRN)’s short sellers to cover AMRN’s short positions. The SI to Amarin Corporation Plc Ads’s float is 3.72%. About 1.02M shares traded. Amarin Corporation plc (ADR) (NASDAQ:AMRN) has risen 76.19% since September 25, 2016 and is uptrending. It has outperformed by 59.49% the S&P500.

Amarin Corporation plc is a biopharmaceutical firm with activities in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The company has market cap of $920.69 million. The Firm operates through the development and commercialization of Vascepa segment. It currently has negative earnings. The Company’s lead product, Vascepa capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Investors sentiment decreased to 1.03 in Q2 2017. Its down 0.21, from 1.24 in 2017Q1. It worsened, as 10 investors sold Amarin Corporation plc (ADR) shares while 27 reduced holdings. 16 funds opened positions while 22 raised stakes. 100.78 million shares or 1.09% less from 101.89 million shares in 2017Q1 were reported. Broadfin Ltd accumulated 1.24% or 2.53M shares. J Goldman & Ltd Partnership accumulated 52,000 shares. Blackrock reported 3.81 million shares. 60,000 were accumulated by Hsbc Plc. Citadel Advsrs Llc reported 0% of its portfolio in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Baker Bros Advsrs L P has 0.8% invested in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Geode Capital Mgmt Ltd holds 0% or 179,270 shares. Wells Fargo And Com Mn stated it has 0% in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Williams Jones & Associate Limited Liability Corporation stated it has 19,198 shares. Mariner Wealth Advsrs Limited Liability Corp invested 0.02% in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Point72 Asset Mngmt Limited Partnership holds 725,200 shares. Raymond James Advsrs invested in 0% or 142,550 shares. State Street has invested 0% of its portfolio in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Clearbridge Ltd stated it has 0.35% in Amarin Corporation plc (ADR) (NASDAQ:AMRN). Ameriprise Financial Inc accumulated 381,499 shares or 0% of the stock.

Among 4 analysts covering Amarin Corp (NASDAQ:AMRN), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amarin Corp had 11 analyst reports since May 12, 2016 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Tuesday, June 27. The rating was maintained by Cantor Fitzgerald with “Buy” on Tuesday, August 29. The company was maintained on Thursday, June 1 by H.C. Wainwright. On Thursday, May 12 the stock rating was initiated by Jefferies with “Buy”. The rating was maintained by Cantor Fitzgerald with “Buy” on Monday, June 12. Cantor Fitzgerald initiated Amarin Corporation plc (ADR) (NASDAQ:AMRN) rating on Wednesday, October 5. Cantor Fitzgerald has “Buy” rating and $6 target. As per Monday, June 26, the company rating was maintained by Cantor Fitzgerald. The stock of Amarin Corporation plc (ADR) (NASDAQ:AMRN) earned “Buy” rating by Cantor Fitzgerald on Monday, August 14. Jefferies maintained the stock with “Buy” rating in Monday, June 12 report. As per Wednesday, October 19, the company rating was initiated by Citigroup.

Analysts await Warrior Met Coal LLC (NYSE:HCC) to report earnings on November, 2. HCC’s profit will be $45.51 million for 7.14 P/E if the $0.85 EPS becomes a reality. After $2.52 actual EPS reported by Warrior Met Coal LLC for the previous quarter, Wall Street now forecasts -66.27% negative EPS growth.

About 149,673 shares traded. Warrior Met Coal LLC (NYSE:HCC) has 0.00% since September 25, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

19 − fourteen =